FINWIRES · TerminalLIVE
FINWIRES

Novartis Says Cosentyx Shows Sustained Remission in Phase 3 Trial

By

Novartis (NVS) said Wednesday new Cosentyx data from a late-stage trial in polymyalgia rheumatica showed a statistically significant, clinically meaningful difference in sustained remission rates against placebo and significant steroid sparing.

The effect of Cosentyx treatment was sustained through week 52, the company said, adding that the trial met all primary and secondary endpoints, and no new safety signals were identified.

Novartis said it has submitted Cosentyx for regulatory review in the US, EU, and Japan, with other filings expected to follow throughout 2026, it added.

Separately, Novartis Canada said it has reached an agreement with the pan-Canadian Pharmaceutical Alliance for the public reimbursement of Scemblix for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.

Price: $143.53, Change: $+0.05, Percent Change: +0.03%

Related Articles

Wire

Update: Sherwin-Williams Shares Rise After Ending Efforts to Acquire AkzoNobel

(Updates with the latest stock movement in the last paragraph and headline.)Sherwin-Williams (SHW) and Nippon Paint Group abandoned their joint attempt to buy AkzoNobel, the companies said Wednesday.The choice follows AkzoNobel's prior dismissal of two combined all-cash buyout proposals submitted by the businesses, according to the companies.Shares of Sherwin-Williams were up about 1.4% in Wednesday trading.Price: $296.74, Change: $+3.74, Percent Change: +1.28%

$SHW
Wire

Market Chatter: Morgan Stanley to Open Wealth Platforms to External AI Agents

Morgan Stanley (MS) will allow clients' artificial intelligence agents to connect directly to its stock administration platforms, ShareWorks and Equity Edge, CNBC reported Wednesday, citing Morgan Stanley at Work Chief Product Officer Mark Mitchell.The move would allow autonomous agents to pull data and insights directly from the platforms, bypassing traditional interfaces built for human users, Mitchell told CNBC.The bank has already granted early access to a handful of clients and plans to expand it to all 3,400 corporate administration clients by next year, Mitchell added, according to the report.Morgan Stanley did not immediately respond to a request for comment from.Rivals JPMorgan Chase (JPM) and Goldman Sachs (GS) are using AI agents internally but have yet to announce steps to open their systems to external agents, CNBC said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $211.14, Change: $-3.84, Percent Change: -1.79%

$GS$JPM$MS
Wire

Calix Secures FCC Conditional Approval for Gateway Appliances

Calix (CALX) said Wednesday that the US Federal Communications Commission Public Safety and Homeland Security Bureau has recognized conditional approval from the US Department of Defense, permitting the continued import, sale, and deployment of all its gateway appliances.The conditional approval exempts the gateway devices from the commission's covered list, removing associated restrictions, the company said.Existing equipment authorizations will remain valid, with the company continuing to provide software, security, and firmware updates for its current installations, it added.Price: $38.74, Change: $-0.76, Percent Change: -1.91%

$CALX